ANC 0 3 0 3 B-clinical_variable
< 4 5 4 5 O
1.5 6 9 6 9 B-upper_bound
K 10 11 10 11 I-upper_bound
/ 11 12 11 12 I-upper_bound
mcL 12 15 12 15 I-upper_bound
, 15 16 15 16 O
Platelets 17 26 17 26 B-clinical_variable
< 27 28 27 28 O
100 29 32 29 32 B-upper_bound
K 33 34 33 34 I-upper_bound
/ 34 35 34 35 I-upper_bound
mcL 35 38 35 38 I-upper_bound
, 38 39 38 39 O
Hemoglobin 40 50 40 50 B-clinical_variable
< 51 52 51 52 O
9.0 53 56 53 56 B-upper_bound
g 57 58 57 58 I-upper_bound
/ 58 59 58 59 I-upper_bound
dl 59 61 59 61 I-upper_bound

AST 0 3 62 65 B-clinical_variable
> 4 5 66 67 O
1.5 6 9 68 71 B-lower_bound
x 10 11 72 73 I-lower_bound
ULN 12 15 74 77 I-lower_bound
, 15 16 77 78 O
ALT>1.5 17 24 79 86 B-clinical_variable
x 25 26 87 88 O
ULN 27 30 89 92 O
and 31 34 93 96 O
Bilirubin 35 44 97 106 B-clinical_variable
> 45 46 107 108 O
1.5 47 50 109 112 O
x 51 52 113 114 O
ULN 53 56 115 118 O

Active 0 6 119 125 O
chronic 7 14 126 133 O
Hepatitis 15 24 134 143 B-chronic_disease
C 25 26 144 145 I-chronic_disease
and/or 27 33 146 152 I-chronic_disease
B 34 35 153 154 I-chronic_disease
infection 36 45 155 164 I-chronic_disease

Age≥18 0 6 165 171 B-age
years 7 12 172 177 I-lower_bound

Concomitant 0 11 178 189 O
treatment 12 21 190 199 O
with 22 26 200 204 O
any 27 30 205 208 O
of 31 33 209 211 O
the 34 37 212 215 O
following 38 47 216 225 O
drugs 48 53 226 231 O
: 53 54 231 232 O
azathioprine 55 67 233 245 B-treatment
, 67 68 245 246 O
cyclophosphamide 69 85 247 263 B-treatment
, 85 86 263 264 O
cyclosporine 87 99 265 277 B-treatment
, 99 100 277 278 O
pirfenidone 101 112 279 290 B-treatment
, 112 113 290 291 O
full 114 118 292 296 B-treatment
dose 119 123 297 301 I-treatment
anticoagulation 124 139 302 317 I-treatment
( 140 141 318 319 O
vitamin 141 148 319 326 B-treatment
K 149 150 327 328 I-treatment
antagonists 151 162 329 340 I-treatment
, 162 163 340 341 O
dabigatran 164 174 342 352 B-treatment
, 174 175 352 353 O
heparin 176 183 354 361 B-treatment
, 183 184 361 362 O
etc 185 188 363 366 O
. 188 189 366 367 O
) 189 190 367 368 O
, 190 191 368 369 O
fibrinolysis 192 204 370 382 B-treatment
and 205 208 383 386 O
high 209 213 387 391 B-treatment
dose 214 218 392 396 I-treatment
anti 219 223 397 401 I-treatment
- 223 224 401 402 I-treatment
platelet 224 232 402 410 I-treatment
therapy 233 240 411 418 I-treatment
( 241 242 419 420 O
ex 242 244 420 422 O
. 244 245 422 423 O
Plavix 246 252 424 430 O
150mg)^2 253 261 431 439 O
Myocardial 262 272 440 450 B-chronic_disease
infarction 273 283 451 461 I-chronic_disease
or 284 286 462 464 O
unstable 287 295 465 473 B-chronic_disease
angina 296 302 474 480 I-chronic_disease
within 303 309 481 487 O
6 310 311 488 489 B-upper_bound
or 312 314 490 492 O
1 315 316 493 494 B-lower_bound
month 317 322 495 500 I-lower_bound
of 323 325 501 503 O
starting 326 334 504 512 O
nintedanib 335 345 513 523 B-treatment
treatment 346 355 524 533 O
, 355 356 533 534 O
respectively 357 369 535 547 O

Current 0 7 548 555 O
oral 8 12 556 560 B-treatment
steroid 13 20 561 568 I-treatment
use 21 24 569 572 O
> 25 26 573 574 O
4 27 28 575 576 B-upper_bound
weeks 29 34 577 582 I-upper_bound
prior 35 40 583 588 I-upper_bound
to 41 43 589 591 O
registration 44 56 592 604 O

Diagnosis 0 9 605 614 O
of 10 12 615 617 O
diffuse 13 20 618 625 O
radiation 21 30 626 635 B-chronic_disease
pneumonitis 31 42 636 647 I-chronic_disease

Gastrointestinal 0 16 648 664 B-chronic_disease
disorders 17 26 665 674 I-chronic_disease
that 27 31 675 679 O
would 32 37 680 685 O
interfere 38 47 686 695 O
with 48 52 696 700 O
drug 53 57 701 705 O
absorption 58 68 706 716 O

Histologically 0 14 717 731 O
/ 14 15 731 732 O
cytologically 15 28 732 745 O
proven 29 35 746 752 O
primary 36 43 753 760 B-cancer
thoracic 44 52 761 769 I-cancer
or 53 55 770 772 O
breast 56 62 773 779 B-cancer
malignancy 63 73 780 790 I-cancer
, 73 74 790 791 O
lymphoma 75 83 792 800 B-cancer
or 84 86 801 803 O
lung 87 91 804 808 B-cancer
metastases 92 102 809 819 I-cancer
( 103 104 820 821 O
which 104 109 821 826 O
are 110 113 827 830 O
not 114 117 831 834 O
required 118 126 835 843 O
to 127 129 844 846 O
be 130 132 847 849 O
biopsy 133 139 850 856 O
- 139 140 856 857 O
proven 140 146 857 863 O
) 146 147 863 864 O
treated 148 155 865 872 O
with 156 160 873 877 O
definitive 161 171 878 888 O
intent 172 178 889 895 O
at 179 181 896 898 O
MSK 182 185 899 902 B-treatment

History 0 7 903 910 O
of 8 10 911 913 O
a 11 12 914 915 O
gastrointestinal 13 29 916 932 B-chronic_disease
perforation 30 41 933 944 I-chronic_disease

History 0 7 945 952 O
of 8 10 953 955 O
bleeding 11 19 956 964 B-chronic_disease
disorders 20 29 965 974 I-chronic_disease
or 30 32 975 977 O
thrombotic 33 43 978 988 B-chronic_disease
events 44 50 989 995 O
, 50 51 995 996 O
e.g. 52 56 997 1001 O
hemorrhagic 57 68 1002 1013 O
or 69 71 1014 1016 O
thrombotic 72 82 1017 1027 O
events 83 89 1028 1034 O
within 90 96 1035 1041 O
12 97 99 1042 1044 B-upper_bound
months 100 106 1045 1051 I-upper_bound

Inherited 0 9 1052 1061 O
predisposition 10 24 1062 1076 O
to 25 27 1077 1079 O
bleeding 28 36 1080 1088 O
or 37 39 1089 1091 O
thrombosis 40 50 1092 1102 B-chronic_disease
, 50 51 1102 1103 O
INR 52 55 1104 1107 B-clinical_variable
> 56 57 1108 1109 O
2 57 58 1109 1110 B-lower_bound
, 58 59 1110 1111 O
PT 60 62 1112 1114 B-clinical_variable
and 63 66 1115 1118 O
PTT 67 70 1119 1122 B-clinical_variable
> 71 72 1123 1124 O
1.5x 72 76 1124 1128 B-lower_bound
ULN 77 80 1129 1132 I-lower_bound

KPS 0 3 1133 1136 B-clinical_variable
> 4 5 1137 1138 O
70 6 8 1139 1141 B-lower_bound
% 8 9 1141 1142 I-lower_bound

Known 0 5 1143 1148 O
inherited 6 15 1149 1158 O
predisposition 16 30 1159 1173 O
to 31 33 1174 1176 O
thrombosis 34 44 1177 1187 B-chronic_disease

Liver 0 5 1188 1193 B-cancer
metastases 6 16 1194 1204 I-cancer

Mean 0 4 1205 1209 O
esophageal 5 15 1210 1220 B-clinical_variable
radiation 16 25 1221 1230 I-clinical_variable
dose 26 30 1231 1235 I-clinical_variable
> 31 32 1236 1237 O
45 32 34 1237 1239 B-lower_bound
Gy 35 37 1240 1242 I-lower_bound

Newly 0 5 1243 1248 O
diagnosed 6 15 1249 1258 O
clinical 16 24 1259 1267 O
grade 25 30 1268 1273 B-lower_bound
2 31 32 1274 1275 I-lower_bound
or 33 35 1276 1278 O
higher 36 42 1279 1285 O
radiation 43 52 1286 1295 B-chronic_disease
pneumonitis 53 64 1296 1307 I-chronic_disease
according 65 74 1308 1317 O
to 75 77 1318 1320 O
CTCAE 78 83 1321 1326 O
version 84 91 1327 1334 O
4.0 92 95 1335 1338 O
criteria 96 104 1339 1347 O

Ongoing 0 7 1348 1355 O
treatment 8 17 1356 1365 B-treatment
with 18 22 1366 1370 O
radiotherapy 23 35 1371 1383 B-treatment
to 36 38 1384 1386 O
thorax 39 45 1387 1393 O
, 45 46 1393 1394 O
cytotoxic 47 56 1395 1404 B-treatment
or 57 59 1405 1407 O
biological 60 70 1408 1418 B-treatment
therapies 71 80 1419 1428 I-treatment
for 81 84 1429 1432 O
this 85 89 1433 1437 O
malignancy 90 100 1438 1448 B-cancer

Other 0 5 1449 1454 O
active 6 12 1455 1461 B-cancer
malignancies 13 25 1462 1474 I-cancer
requiring 26 35 1475 1484 O
oncologic 36 45 1485 1494 B-treatment
treatment 46 55 1495 1504 I-treatment

Other 0 5 1505 1510 O
investigational 6 21 1511 1526 B-treatment
therapy 22 29 1527 1534 I-treatment
received 30 38 1535 1543 O
within 39 45 1544 1550 O
8 46 47 1551 1552 B-upper_bound
weeks 48 53 1553 1558 I-upper_bound
prior 54 59 1559 1564 I-upper_bound
to 60 62 1565 1567 O
screening 63 72 1568 1577 O
visit 73 78 1578 1583 O

Patient 0 7 1584 1591 O
with 8 12 1592 1596 O
a 13 14 1597 1598 O
history 15 22 1599 1606 O
of 23 25 1607 1609 O
a 26 27 1610 1611 O
thrombotic 28 38 1612 1622 B-chronic_disease
event 39 44 1623 1628 I-chronic_disease
within 45 51 1629 1635 O
12 52 54 1636 1638 B-upper_bound
months 55 61 1639 1645 I-upper_bound
of 62 64 1646 1648 O
starting 65 73 1649 1657 O
nintedanib 74 84 1658 1668 B-treatment
treatment 85 94 1669 1678 I-treatment

Patients 0 8 1679 1687 O
with 9 13 1688 1692 O
severe 14 20 1693 1699 B-chronic_disease
hepatic 21 28 1700 1707 I-chronic_disease
impairment 29 39 1708 1718 I-chronic_disease

Pembrolizumab 0 13 1719 1732 B-treatment
, 13 14 1732 1733 O
Nivolumab 15 24 1734 1743 B-treatment
, 24 25 1743 1744 O
Afatinib 26 34 1745 1753 B-treatment
and 35 38 1754 1757 O
all 39 42 1758 1761 O
hormonal 43 51 1762 1770 B-treatment
therapies 52 61 1771 1780 I-treatment

Pregnant 0 8 1781 1789 B-pregnancy
women 9 14 1790 1795 B-gender
or 15 17 1796 1798 O
women 18 23 1799 1804 O
who 24 27 1805 1808 O
are 28 31 1809 1812 O
breast 32 38 1813 1819 O
feeding 39 46 1820 1827 O
or 47 49 1828 1830 O
of 50 52 1831 1833 O
child 53 58 1834 1839 O
bearing 59 66 1840 1847 O
potential 67 76 1848 1857 O
not 77 80 1858 1861 O
using 81 86 1862 1867 O
a 87 88 1868 1869 O
highly 89 95 1870 1876 O
effective 96 105 1877 1886 O
method 106 112 1887 1893 O
of 113 115 1894 1896 O
birth 116 121 1897 1902 O
control 122 129 1903 1910 O
for 130 133 1911 1914 O
at 134 136 1915 1917 O
least 137 142 1918 1923 O
one 143 146 1924 1927 B-lower_bound
month 147 152 1928 1933 I-lower_bound
prior 153 158 1934 1939 I-lower_bound
to 159 161 1940 1942 O
enrollment1 162 173 1943 1954 O

Prior 0 5 1955 1960 B-treatment
treatment 6 15 1961 1970 I-treatment
with 16 20 1971 1975 O
thoracic 21 29 1976 1984 B-treatment
radiotherapy 30 42 1985 1997 I-treatment
completed 43 52 1998 2007 O
> 53 54 2008 2009 O
4 54 55 2009 2010 B-lower_bound
weeks 56 61 2011 2016 I-lower_bound
and 62 65 2017 2020 O
≤ 66 67 2021 2022 O
9 68 69 2023 2024 B-upper_bound
months 70 76 2025 2031 I-upper_bound
prior 77 82 2032 2037 I-upper_bound
to 83 85 2038 2040 O
enrollment 86 96 2041 2051 O

Radiographic 0 12 2052 2064 O
evidence 13 21 2065 2073 O
of 22 24 2074 2076 O
cavitary 25 33 2077 2085 B-cancer
or 34 36 2086 2088 O
necrotic 37 45 2089 2097 B-cancer
tumor 46 51 2098 2103 I-cancer
and 52 55 2104 2107 O
local 56 61 2108 2113 O
invasion 62 70 2114 2122 O
of 71 73 2123 2125 O
major 74 79 2126 2131 O
blood 80 85 2132 2137 O
vessels 86 93 2138 2145 O

Radiographic 0 12 2146 2158 O
evidence 13 21 2159 2167 O
of 22 24 2168 2170 O
radiation 25 34 2171 2180 B-chronic_disease
pneumonitis 35 46 2181 2192 I-chronic_disease
on 47 49 2193 2195 O
a 50 51 2196 2197 O
CT 52 54 2198 2200 B-treatment
scan 55 59 2201 2205 I-treatment
of 60 62 2206 2208 O
the 63 66 2209 2212 O
chest 67 72 2213 2218 O
with 73 77 2219 2223 O
or 78 80 2224 2226 O
without 81 88 2227 2234 O
contrast 89 97 2235 2243 O

Reduction 0 9 2244 2253 O
of 10 12 2254 2256 O
any 13 16 2257 2260 O
acute 17 22 2261 2266 O
toxicity 23 31 2267 2275 O
from 32 36 2276 2280 O
radiation 37 46 2281 2290 B-treatment
treatment 47 56 2291 2300 I-treatment
to 57 59 2301 2303 O
grade 60 65 2304 2309 O
1 66 67 2310 2311 O

Sexually 0 8 2312 2320 O
active 9 15 2321 2327 O
males 16 21 2328 2333 B-gender
not 22 25 2334 2337 O
committing 26 36 2338 2348 O
to 37 39 2349 2351 O
birth 40 45 2352 2357 O
control 46 53 2358 2365 O
during 54 60 2366 2372 O
the 61 64 2373 2376 O
course 65 71 2377 2383 O
of 72 74 2384 2386 O
the 75 78 2387 2390 O
study 79 84 2391 2396 O
( 85 86 2397 2398 O
except 86 92 2398 2404 O
if 93 95 2405 2407 O
their 96 101 2408 2413 O
partner 102 109 2414 2421 O
is 110 112 2422 2424 O
not 113 116 2425 2428 O
of 117 119 2429 2431 O
childbearing 120 132 2432 2444 O
potential 133 142 2445 2454 O
) 142 143 2454 2455 O

Untreated 0 9 2456 2465 B-cancer
or 10 12 2466 2468 I-cancer
symptomatic 13 24 2469 2480 I-cancer
brain 25 30 2481 2486 I-cancer
metastases 31 41 2487 2497 I-cancer
or 42 44 2498 2500 O
leptomeningeal 45 59 2501 2515 B-cancer
disease 60 67 2516 2523 I-cancer

active 0 6 2524 2530 B-chronic_disease
gastrointestinal 7 23 2531 2547 I-chronic_disease
bleeding 24 32 2548 2556 I-chronic_disease
or 33 35 2557 2559 O
ulcers 36 42 2560 2566 O
or 43 45 2567 2569 O
major 46 51 2570 2575 O
injuries 52 60 2576 2584 O
or 61 63 2585 2587 O
surgery 64 71 2588 2595 B-treatment

clinically 0 10 2596 2606 O
significant 11 22 2607 2618 O
or 23 25 2619 2621 O
tumor 26 31 2622 2627 B-cancer
- 31 32 2627 2628 O
related 32 39 2628 2635 O
hemoptysis 40 50 2636 2646 B-cancer

non 0 3 2647 2650 B-cancer
- 3 4 2650 2651 I-cancer
melanoma 4 12 2651 2659 I-cancer
skin 13 17 2660 2664 I-cancer
cancer 18 24 2665 2671 I-cancer
, 24 25 2671 2672 O
superficial 26 37 2673 2684 B-cancer
bladder 38 45 2685 2692 I-cancer
cancer 46 52 2693 2699 I-cancer
etc 53 56 2700 2703 O
. 56 57 2703 2704 O
are 58 61 2705 2708 O
eligible 62 70 2709 2717 O

≥ 0 1 2718 2719 O
Grade 2 7 2720 2725 B-lower_bound
2 8 9 2726 2727 I-lower_bound
proteinuria 10 21 2728 2739 B-clinical_variable
, 21 22 2739 2740 O
creatinine 23 33 2741 2751 B-clinical_variable
> 34 35 2752 2753 O
1.5x 35 39 2753 2757 B-lower_bound
ULN 40 43 2758 2761 I-lower_bound
or 44 46 2762 2764 O
GFR 47 50 2765 2768 B-clinical_variable
< 51 52 2769 2770 O
45 52 54 2770 2772 B-upper_bound
ml 55 57 2773 2775 I-upper_bound
/ 57 58 2775 2776 I-upper_bound
min 58 61 2776 2779 I-upper_bound

